European mammography Market 2026-2035

Description

List of Tables

European Mammography Market Size, Share & Trends Analysis Report by Product Type (Digital Systems, Analog Systems, Biopsy Systems, Film Screen Systems, and Others), By End-User (Hospitals & Clinics and Diagnostics Centers), Forecast Period (2026-2035)

Industry Overview

European mammography market was valued at $828.3 million in 2025 and is projected to reach $1,986.9 million by 2035, growing at a CAGR of 9.2% during the forecast period (2026-2035). The mammography market across Europe continues to expand, supported by the rising focus on early breast cancer detection and the modernization of healthcare infrastructure. Continuous investment in diagnostic imaging technologies is enhancing the precision and accessibility of screening programs. Increasing government funding and public awareness initiatives have encouraged women to participate in regular breast examinations. Innovation in imaging systems is enabling clinicians to detect subtle abnormalities more effectively.

Market Dynamics

Growing Adoption of 3D Mammography Systems

Three-dimensional mammography, or tomosynthesis, is becoming a preferred screening method across Europe due to its superior accuracy in detecting early-stage cancers. Hospitals and diagnostic centers are increasingly investing in 3D systems to improve patient outcomes and reduce recall rates. Companies such as Hologic and GE Healthcare have launched advanced tomosynthesis platforms that deliver clearer imaging results with lower radiation exposure. These technologies are now part of national screening programs in several European countries. Improved diagnostic confidence is encouraging broader clinical adoption.

Expansion of AI and Digital Imaging Integration

Artificial intelligence and digital imaging tools are reshaping mammography workflows by automating image interpretation and enhancing diagnostic accuracy. European healthcare providers are integrating AI-enabled software for faster and more consistent analysis of mammograms. Firms like ScreenPoint Medical and Therapixel have developed AI solutions that assist radiologists in identifying early cancer signs. The incorporation of these systems has improved efficiency and reduced human error. Partnerships between technology developers and medical institutions are accelerating implementation.

Market Segmentation

Based on the product type, the market is segmented into digital systems, analog systems, biopsy systems, film screen systems, and others.
Based on the application, the market is segmented into hospitals & clinics and diagnostic centers.

Digital Systems Segment to Lead the Market with the Largest Share

The transition toward digital mammography systems remains one of the key forces behind market expansion in Europe. Digital platforms provide higher image resolution, faster processing times, and seamless data storage compared to conventional film-based systems. Siemens Healthineers, with its Mammomat Revelation and Inspiration series, continues to deliver innovative digital imaging solutions across the region. These systems help clinicians make more accurate diagnoses while enhancing patient comfort. Healthcare providers are upgrading to digital technology to meet national screening standards and efficiency goals. Such technological evolution is ensuring long-term growth and modernization of breast imaging services.

Hospitals & Clinics: A Key Segment in Market Growth

Hospitals and clinics are playing a central role in advancing the European mammography market. The growing number of women undergoing routine screenings has prompted healthcare facilities to invest in advanced diagnostic solutions. Philips Healthcare and Canon Medical Systems Europe are among the providers offering integrated mammography equipment designed for clinical use. These systems improve workflow efficiency and patient management, making them ideal for large-scale screening programs. Public and private healthcare institutions are also partnering with technology providers to expand access to quality imaging.

Regional Outlook

European mammography market is further divided by countries, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.

Germany Dominates the Market with Major Share

Germany's mammography market is witnessing notable growth, supported by nationwide screening programs and strong healthcare funding. The country's emphasis on preventive health measures has driven widespread adoption of high-performance imaging systems. Hologic and Siemens Healthineers, both active in Germany, supply advanced 3D and digital mammography platforms tailored to local clinical needs. Hospitals and diagnostic centers are upgrading existing systems to meet regulatory quality standards. Collaboration between research institutes and manufacturers is promoting innovation in imaging precision.

Market Players Outlook

The major companies operating in the European mammography market include Fujifilm, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Siemens Healthineers, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In November 2024, GE HealthCare launched the Pristina Via mammography system-the newest evolution in its Senographe Pristina line-offering zero-click image acquisition, no wait times, reduced radiation across all breast thicknesses, and a vendor-neutral prior-image comparison for streamlined workflow.
In October 2025, Vara, a Berlin-based company, received CE certification for its new AI-powered mammography platform. This is the only AI in Europe authorized to act as an independent second reader for both screening and diagnostic mammograms, supporting national programs like Germany's and helping to address radiologist shortages.
In September 2025, Hologic showcased its latest AI-powered mammography technology (Envision platform) and new breast biopsy systems at EUSOBI 2024. The new system enhanced AI for early breast cancer detection and integration with expanded diagnostic and biopsy workflows, plus partnerships for contrast-enhanced mammography.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the European mammography market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023642

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
European Mammography Market Sales Analysis - Product Type | End-User | ($ Million)
European Mammography Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key European Mammography Industry Trends
- 2.2.2. Market Recommendations

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For European Mammography Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For European Mammography Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - European Mammography Market Revenue and Share by Manufacturers
Mammography Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Fujifilm
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. GE Healthcare
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Hologic
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Koninklijke Philips N.V.
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Siemens Healthineers
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. European Mammography Market Sales Analysis by Product Type ($ Million)

5.1. Digital Systems
5.2. Analog Systems
5.3. Biopsy Systems
5.4. Film Screen System
5.5. Others (3D Systems)

6. European Mammography Market Sales Analysis by End-User ($ Million)

6.1. Hospital & Clinics
6.2. Diagnostic Centers

7. Regional Analysis

7.1. European Mammography Market Sales Analysis - Product Type | End-User | Country ($ Million)
Macroeconomic Factors for Europe
- 7.1.1. UK
- 7.1.2. Germany
- 7.1.3. Italy
- 7.1.4. Spain
- 7.1.5. France
- 7.1.6. Russia
- 7.1.7. Rest of Europe

8. Company Profiles

8.1. Agfa-Gevaert
- 8.1.1. Quick Facts
- 8.1.2. Company Overview
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategies
8.2. Barco NV
- 8.2.1. Quick Facts
- 8.2.2. Company Overview
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategies
8.3. Bayer AG
- 8.3.1. Quick Facts
- 8.3.2. Company Overview
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategies
8.4. Canon Medical Systems Europe B.V.
- 8.4.1. Quick Facts
- 8.4.2. Company Overview
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategies
8.5. Carestream Health Europe
- 8.5.1. Quick Facts
- 8.5.2. Company Overview
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategies
8.6. Esaote S.p.A.
- 8.6.1. Quick Facts
- 8.6.2. Company Overview
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategies
8.7. Fujifilm Europe GmbH
- 8.7.1. Quick Facts
- 8.7.2. Company Overview
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategies
8.8. GE Healthcare Europe
- 8.8.1. Quick Facts
- 8.8.2. Company Overview
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategies
8.9. General Medical Italia S.p.A.
- 8.9.1. Quick Facts
- 8.9.2. Company Overview
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategies
8.10. Hera-MI SAS
- 8.10.1. Quick Facts
- 8.10.2. Company Overview
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategies
8.11. Hologic Inc.
- 8.11.1. Quick Facts
- 8.11.2. Company Overview
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategies
8.12. IMS Giotto S.p.A.
- 8.12.1. Quick Facts
- 8.12.2. Company Overview
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategies
8.13. INFINITT Europe Ltd.
- 8.13.1. Quick Facts
- 8.13.2. Company Overview
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategies
8.14. Konica Minolta Europe GmbH
- 8.14.1. Quick Facts
- 8.14.2. Company Overview
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategies
8.15. Koninklijke Philips N.V.
- 8.15.1. Quick Facts
- 8.15.2. Company Overview
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategies
8.16. Metaltronica S.p.A.
- 8.16.1. Quick Facts
- 8.16.2. Company Overview
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategies
8.17. Planmed Oy
- 8.17.1. Quick Facts
- 8.17.2. Company Overview
- 8.17.3. Product Portfolio
- 8.17.4. Business Strategies
8.18. Sectra AB
- 8.18.1. Quick Facts
- 8.18.2. Company Overview
- 8.18.3. Product Portfolio
- 8.18.4. Business Strategies
8.19. Siemens Healthineers AG
- 8.19.1. Quick Facts
- 8.19.2. Company Overview
- 8.19.3. Product Portfolio
- 8.19.4. Business Strategies
8.20. Villa Sistemi Medicali S.p.A.
- 8.20.1. Quick Facts
- 8.20.2. Company Overview
- 8.20.3. Product Portfolio
- 8.20.4. Business Strategies